Characteristics of Patients Losing Vision after 2 Years of Monthly Dosing in the Phase III Ranibizumab Clinical Trials
Year: 2010
Type: article
Source: Ophthalmology
Authors: Philip J. Rosenfeld, Howard Shapiro, Lisa Tuomi, Mary Webster, Julee Elledge, Barbara Blodi
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Keywords: ranibizumab, neovascular age-related macular degeneration, visual acuity loss, anti-VEGF therapy, choroidal neovascularization, retinal pigment epithelium abnormalities, geographic atrophy, lesion area, atrophic scars, MARINA trial, ANCHOR trial, treatment safety, fibrosis, hemorrhage, leakage
Open Access status: closed
Funder: Genentech
OpenAlex ID: W2009150210
